Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bispecific antibodies
Biotech
Context builds bispecific bank with $133M biobucks deal
For further context, the antibody binds to Nectin-4 on tumor cells and CD3 on T cells, galvanizing the T cells to attack the cancer.
Darren Incorvaia
Sep 23, 2024 11:20am
Trispecific antibody one-ups Tecvayli in myeloma mouse study
Sep 17, 2024 3:38pm
Candid flashes big ambitions with $370M debut
Sep 9, 2024 9:00am
FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer
Aug 21, 2024 5:48am
Merck pays $700M for bispecific challenger to Amgen cancer drug
Aug 9, 2024 8:52am
Cullinan, after $25M deal, hands back bispecific to Harbour
Aug 8, 2024 10:10am